Evidence map›Paper›PMID 37974152›Full record

ArticleBMC public health2023

Mapping COVID vulnerability in relation to drug and alcohol recovery residence availability across the United States.

Amy A Mericle, Deidre Patterson, Meenakshi S Subbaraman, Jason Howell, Dave Sheridan, Thomasina Borkman, Jayla Burton, Katherine J Karriker-Jaffe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amy A MericleAlcohol Research Group at the Public Health Institute, 6001 Shellmound St., Suite 450, Emeryville, CA, 94608, USA. americle@arg.org.ORCID 0000-0002-5615-0310
Deidre PattersonAlcohol Research Group at the Public Health Institute, 6001 Shellmound St., Suite 450, Emeryville, CA, 94608, USA.
Meenakshi S SubbaramanBehavioral Health and Recovery Studies at the Public Health Institute, Oakland, CA, USA.
Jason HowellRecovery People, Elgin, TX, USA.
Dave SheridanNational Alliance for Recovery Residences, St. Paul, MN, USA.
Thomasina BorkmanGeorge Mason University, Fairfax, VA, USA.
Jayla BurtonAlcohol Research Group at the Public Health Institute, 6001 Shellmound St., Suite 450, Emeryville, CA, 94608, USA.
Katherine J Karriker-JaffeCommunity Health & Implementation Research Program at RTI International, Berkeley, CA, USA.

Funding

Recovery Housing for Alcohol and Drug Use Disorders: A National Study of Availability, Characteristics, and Factors Associated with Evidence-based PracticesR01AA027782 · NIAAA · PUBLIC HEALTH INSTITUTE · PI MERICLE, AMY ADALE · 2019 to 2022
$2.3M
NIAAA NIH HHS R01 AA027782NIAAA NIH HHS R01AA027782-02S1
6 · The paper itself

Abstract

Recovery housing is an important resource for those in recovery from substance use disorders. Unfortunately, we know little about its relationship to key community health risk and protective factors, potentially limiting the role it could play as a broader health resource. Leveraging county-level data on recovery residences from the National Study of Treatment and Addiction Recovery Residences (NSTARR), this study used multilevel modeling to examine Community COVID Vulnerability Index (CCVI) scores as well as availability of COVID testing and vaccination sites in relation to recovery housing. CCVI composite scores were positively associated with recovery housing availability. Analyses using CCVI thematic sub-scores found that population density and number of churches were positively associated with recovery housing availability, while epidemiological factors and healthcare system factors were negatively associated with recovery housing availability. In counties with recovery housing, there also was a positive association between CCVI and both COVID testing and vaccination availability. Recovery residences tend to be located in areas of high COVID vulnerability, reflecting effective targeting in areas with higher population density, more housing risk factors, and other high-risk environments and signaling a key point of contact to address broader health issues among those in recovery from substance use disorders.

Indexed as

COVID-19Substance-Related DisordersCOVID-19 TestingHousingHumansRisk FactorsUnited StatesCOVIDCOVID vulnerabilityRecovery housingRecovery residencesSocial determinants of health

Identifiers

PMID37974152
PMCPMC10655292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.